2,560
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Exploring the pharmacological mechanisms of Shuanghuanglian against T-cell acute lymphoblastic leukaemia through network pharmacology combined with molecular docking and experimental validation

ORCID Icon, , , , , , ORCID Icon, , , , & show all
Pages 259-270 | Received 18 Jul 2022, Accepted 10 Jan 2023, Published online: 19 Jan 2023

References

  • Adrián M, Maribel FC, Darnel MM, Rocío B, Jesús H. 2018. New challenges in targeting signaling pathways in acute lymphoblastic leukemia by NGS approaches: an update. Cancers. 10:110–134.
  • Ahamed M, Akhtar MJ, Khan M, Alhadlaq HA. 2022. Enhanced anticancer performance of eco-friendly-prepared Mo-ZnO/RGO nanocomposites: role of oxidative stress and apoptosis. ACS Omega. 7(8):7103–7115.
  • Anand P, Guillaumet-Adkins A, Dimitrova V, Yun H, Drier Y, Sotudeh N, Rogers A, Ouseph MM, Nair M, Potdar S, et al. 2021. Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL. Blood. 137(18):2463–2480.
  • Asselin BL, Devidas M, Chen L, Franco VI, Pullen J, Borowitz MJ, Hutchison RE, Ravindranath Y, Armenian SH, Camitta BM, et al. 2016. Cardioprotection and safety of dexrazoxane in patients treated for newly diagnosed T-cell acute lymphoblastic leukemia or advanced-stage lymphoblastic non-Hodgkin lymphoma: a report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404. J Clin Oncol. 34(8):854–862.
  • Bayón-Calderón F, Toribio ML, González-García S. 2020. Facts and challenges in immunotherapy for T-cell acute lymphoblastic leukemia. IJMS. 21(20):7685–7720.
  • Belver L, Yang AY, Albero R, Herranz D, Brundu FG, Quinn SA, Pérez-Durán P, Álvarez S, Gianni F, Rashkovan M, et al. 2019. GATA3-Controlled nucleosome eviction drives MYC enhancer activity in T-cell development and leukemia. Cancer Discov. 9(12):1774–1791.
  • Bray SJ, Gomez-Lamarca M. 2018. Notch after cleavage. Curr Opin Cell Biol. 51:103–109.
  • Casas AI, Hassan AA, Larsen SJ, Gomez-Rangel V, Elbatreek M, Kleikers PWM, Guney E, Egea J, López MG, Baumbach J, et al. 2019. From single drug targets to synergistic network pharmacology in ischemic stroke. Proc Natl Acad Sci U S A. 116(14):7129–7136.
  • Chen L, Zhong L. 2020. Genomics functional analysis and drug screening of SARS-CoV-2. Genes Dis. 7(4):542–550.
  • Chen PY, Tien HJ, Chen SF, Horng CT, Tang HL, Jung HL, Wu MJ, Yen JH. 2018. Response of myeloid leukemia cells to luteolin is modulated by differentially expressed pituitary tumor-transforming gene 1 (PTTG1) oncoprotein. Int J Mol Sci. 19:1–9.
  • Darband SG, Kaviani M, Yousefi B, Sadighparvar S, Pakdel FG, Attari JA, Mohebbi I, Naderi S, Majidinia M. 2018. Quercetin: a functional dietary flavonoid with potential chemo‐preventive properties in colorectal cancer. J Cell Physiol. 233(9):6544–6560.
  • Desroches A, Denault JB. 2019. PNAS Plus: caspase-7 uses RNA to enhance proteolysis of poly(ADP-ribose) polymerase 1 and other RNA-binding proteins. Proc Natl Acad Sci U S A. 116(43):21521–21528.
  • Fattizzo B, Rosa J, Giannotta JA, Baldini L, Fracchiolla NS. 2020. The physiopathology of T- cell acute lymphoblastic leukemia: focus on molecular aspects. Front Oncol. 10:273.
  • Green DR. 2019. The coming decade of cell death research: five riddles. Cell. 177(5):1094–1107.
  • Guo B, Zhao C, Zhang C, Xiao Y, Yan G, Liu L, Pan H. 2022. Elucidation of the anti-inflammatory mechanism of Er Miao San by integrative approach of network pharmacology and experimental verification. Pharmacol Res. 175:106000.
  • Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. 2005. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 3: D514–D517.
  • Han X, Liu C-F, Gao N, Zhao J, Xu J. 2018. Kaempferol suppresses proliferation but increases apoptosis and autophagy by up-regulating microRNA-340 in human lung cancer cells. Biomed Pharmacother. 108:809–816.
  • Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, Hermiston ML, Teachey DT, Perkins SL, Miles RR, et al. 2020. Successful outcomes of newly diagnosed t lymphoblastic lymphoma: results from Children’s Oncology Group AALL0434. J Clin Oncol. 38(26):3062–3070.
  • Iraji A, Khoshneviszadeh M, Firuzi O, Khoshneviszadeh M, Edraki N. 2020. Novel small molecule therapeutic agents for Alzheimer disease: focusing on BACE1 and multi-target directed ligands. Bioorg Chem. 97:103649.
  • Jia CY, Li JY, Hao GF, Yang GF. 2020. A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discov Today. 25(1):248–258.
  • Lato MW, Przysucha A, Grosman S, Zawitkowska J, Lejman M. 2021. The new therapeutic strategies in pediatric T-cell acute lymphoblastic leukemia. IJMS. 22(9):4502–4516.
  • Lee JH, Kim C, Lee J, Um J-Y, Sethi G, Ahn KS. 2019. Arctiin is a pharmacological inhibitor of STAT3 phosphorylation at tyrosine 705 residue and potentiates bortezomib-induced apoptotic and anti-angiogenic effects in human multiple myeloma cells. Phytomedicine. 55:282–292.
  • Li Y, Yang M, Meng T, Niu Y, Dai Y, Zhang L, Zheng X, Jalava P, Dong G, Gao W, et al. 2020. Oxidative stress induced by ultrafine carbon black particles can elicit apoptosis in vivo and in vitro. Sci Total Environ. 709:135802.
  • Liu Y, Yang S, Wang K, Lu J, Bao X, Wang R, Qiu Y, Wang T, Yu H. 2020. Cellular senescence and cancer: focusing on traditional Chinese medicine and natural products. Cell Prolif. 53(10):e12894.
  • Ma Q, Liang D, Song S, Yu Q, Shi C, Xing X, Luo JB. 2017. Comparative study on the antivirus activity of Shuang-Huang-Lian injectable powder and its bioactive compound mixture against human adenovirus III in vitro. Viruses. 9(4):79–79.
  • Malard F, Mohty M. 2020. Acute lymphoblastic leukaemia. Lancet. 395(10230):1146–1162.
  • Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, Dharia NV, Montgomery PG, Cowley GS, Pantel S, et al. 2017. Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nat Genet. 49(12):1779–1784.
  • Park JY, Kim HD, Lee SH, Kwak CH, Chang YC, Lee YC, Chung TW, Magae J, Kim CH. 2019. Ascochlorin induces caspase-independent necroptosis in LPS-stimulated RAW 264.7 macrophages. J Ethnopharmacol. 239:111898.
  • Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. 1997. GeneCards: integrating information about genes, proteins and diseases. Trends Genet. 13(4):163.
  • Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al. 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 6:13.
  • Sanchez-Martin M, Ferrando A. 2017. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood. 129(9):1124–1133.
  • Shi B, Ding J, Qi J, Gu Z. 2021. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap. Int J Med Sci. 18(9):2063–2075.
  • Sprinzak D, Blacklow SC. 2021. Biophysics of Notch signaling. Annu Rev Biophys. 50:157–189.
  • Su HX, Yao S, Zhao WF, Li MJ, Liu J, Shang WJ, Xie H, Ke CQ, Hu HC, Gao MN, et al. 2020. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 41:1167–1177.
  • Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. 2019. The molecular machinery of regulated cell death. Cell Res. 29:347–364.
  • Tang W, Shi Q, Ma T, Jiang X, Liu S, Wang Y. 2016. Meta-analysis on incidence of adverse drug reaction induced by Shuanghuanglian injection. China J Chinese Materia Med. 41:2732–2742. Chinese.
  • Teachey DT, Connor D. 2020. How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children - ScienceDirect. Blood. 135(3):159–166.
  • Wang J, Liu X, Qiu Y, Shi Y, Cai J, Wang B, Wei X, Ke Q, Sui X, Wang Y, et al. 2018. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells. J Hematol Oncol. 11(1):1–13.
  • Wang L, Luo Q, Zeng S, Lou Y, Li X, Hu M, Lu L, Liu Z. 2021. Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11‐deficient mice. J Pathol. 255:412–424.
  • Winter S, Dunsmore K, Devidas M, Wood B, Esiashvili N, Chen Z, Eisenberg N, Briegel N, Hayashi R, Gastier-Foster J, et al. 2018. Improved survival for children and young adults with T-lineage acute lymphoblastic leukemia: results from the Children’s Oncology Group AALL0434 methotrexate randomization. J Clin Oncol. 36(29):2926–2934.
  • Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. 2008. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36:D901–D906.
  • Wong VKW, Qiu C, Xu S‐W, Law BYK, Zeng W, Wang H, Michelangeli F, Dias IRDSR, Qu YQ, Chan TW, et al. 2019. Ca2+ signalling plays a role in celastrol‐mediated suppression of synovial fibroblasts of rheumatoid arthritis patients and experimental arthritis in rats. Br J Pharmacol. 176(16):2922–2944.
  • Xu H, Zhang YQ, Qing YW, Zhao H, Liu F. 2020. Exploration on scientific connotation of TCM syndromes and recommended prescriptions against COVID-19 based on TCMTP V2.0. China J Chinese Materia Med. 45:1488–1498. Chinese.
  • Xu Z, Li K, Pan T, Liu J, Li B, Li C, Wang S, Diao Y, Liu X. 2019. Lonicerin, an anti-algE flavonoid against Pseudomonas aeruginosa virulence screened from Shuanghuanglian formula by molecule docking based strategy. J Ethnopharmacol. 239:111909.
  • Yang Y, Zhong F, Huang Z, Qin X, Ma W, Liu W. 2021. Shuanghuanglian freeze-dried powder induced apoptosis of acute B cell lymphocytic leukemia cells (Nalm6) through inhibiting the MEK-ERK signaling pathway. Tianjin Med J. 49:1014–1019. Chinese.
  • Zhang FX, Li ZT, Yang X, Xie ZN, Chen MH, Yao ZH, Chen JX, Yao XS, Dai Y. 2021. Discovery of anti-flu substances and mechanism of Shuang-Huang-Lian water extract based on serum pharmaco-chemistry and network pharmacology. J Ethnopharmacol. 268:113660.
  • Zheng J, Wu M, Wang H, Li S, Wang X, Li Y, Wang D, Li S. 2018. Network pharmacology to inveil the biological basis of health-strengthening herbal medicine in cancer treatment. Cancers. 10(11):461–484.